Nu Skin Enterprises Q1 Earnings Call Highlights
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line with expectations, as the company continued to invest in its Prysm iO wellness platform and emerging-market expansion while navigating macroeconomic pressures on consumers and supply chains.
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Nu Skin Enterprises (NUS) Q1 Earnings and Revenues Lag Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.14 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.23 per share a year ago.
Nu Skin: Patience Is Still Advised
Nu Skin Enterprises trades at a deep value multiple (~3x 2026 EBITDA) but faces persistent core business decline and unproven turnaround catalysts. Guidance disappointed, yet management expects margin expansion and a return to revenue growth by late 2026, with India and Prysm iO launches as key potential drivers. Non-core assets and a net cash-positive balance sheet provide some downside protection, but secular decline in legacy markets remains a major overhang.
Nu Skin Still Has Long-Term Turnaround Potential
Nu Skin is rated a buy, trading at low multiples with turnaround prospects tied to India expansion and Prysm iO device launch. NUS's core MLM business faces structural decline, but new product and market initiatives could stabilize or grow revenue beyond 2026. Prysm iO potential subscription fees may provide incremental revenue not fully reflected in current guidance.
Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y
NUS' fourth-quarter earnings and sales miss estimates, with revenues down 16.9% Y/Y and broad declines across key global regions.
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Miss Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.38 per share a year ago.
Nu Skin Gears Up to Report Q4 Earnings: What's in the Offing?
NUS faces FX and competition headwinds as it guides Q4 revenues down 10-18%, while margin gains and Latin America strength offer support.
Nu Skin Enterprises, Inc. (NUS) Q3 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. ( NUS ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants B.G. Hunt Ryan Napierski - President, CEO & Director James Thomas - Executive VP & CFO Conference Call Participants David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Good day, and thank you for standing by.
Nu Skin to Report Q3 Earnings: What's in the Cards for NUS Stock?
NUS' Q3 results may reflect revenue pressure, but cost savings and efficiency gains are likely to have helped sustain earnings.
Nu Skin Enterprises, Inc. (NUS) Q2 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants B.G. Hunt - Corporate Participant James D.
Nu Skin Enterprises, Inc. (NUS) Q1 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants B.G. Hunt - Investor Relations Ryan Napierski - President & Chief Executive Officer James Thomas - Chief Financial Officer Operator Good day, and thank you for standing by.
